TransEnterix (NYSE:TRXC) shares surged today on speculation that the robot-assisted surgery company could be acquired by Johnson & Johnson (NYSE:JNJ).
Johnson & Johnson chairman & CEO said this week that the healthcare conglomerate stayed off the mergers & acquisitions trail last year because valuations were too high. That’s not the case this year, Gorsky said.
Johnson & Johnson chairman & CEO said this week that the healthcare conglomerate stayed off the mergers & acquisitions trail last year because valuations were too high. That’s not the case this year, Gorsky said.
